Incorporation of natriuretic peptides with clinical risk scores to predict heart failure among individuals with dysglycemia
European Journal of Heart Failure Dec 01, 2021
Segar MW, Khan MS, Patel KV, et al. - Among community-based people with dysglycemia, an accurate prediction of incident heart failure (HF) risk can be achieved by using the WATCH-DM risk score, a clinical risk score. Greater improvement in the HF risk prediction performance was achieved by adding natriuretic peptide (NP) levels, in those with low/intermediate risk vs those with high risk.
Participants (n= 8,938) were adults with diabetes/pre-diabetes free of HF at baseline from four cohort studies (ARIC, CHS, FHS, and MESA); 5-year risk of incident HF was estimated using machine learning- [WATCH-DM(ml)] and integer-based [WATCH-DM(i)] scores.
HF occurred in 4.8% within 5 years, and both above-mentioned scores showed high discrimination for predicting HF risk in people with dysglycemia (C-indices = 0.80 and 0.71, respectively), with no evidence of miscalibration (Greenwood–Nam–D'Agostino P ≥0.10).
Increased NP levels alone had a significantly higher C-index, for predicting incident HF, in those with low/intermediate (<13) vs high (≥13) WATCH-DM(i) scores, among persons with dysglycemia [0.71 vs 0.64].
On integrating NP levels with the WATCH-DM(i) score, HF risk discrimination improvement and net reclassification improvement (NRI) differed across the spectrum of risk with greater improvement noted at low/intermediate risk [WATCH-DM(i) <13] vs high risk [WATCH-DM(i) ≥13] (C-index = 0.73 vs 0.71; NRI = 0.45 vs 0.17).
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries